Hasil Pencarian - Sandeep K. Srivastava
Anda harus masuk terlebih dahulu
- Menampilkan 1 - 4 hasil dari 4
-
1
-
2
KS18, a Mcl-1 inhibitor, improves the effectiveness of bortezomib and overcomes resistance in refractory multiple myeloma by triggering intrinsic apoptosis oleh Omar S. Al-Odat, Omar S. Al-Odat, Weam Othman Elbezanti, Weam Othman Elbezanti, Krishne Gowda, Sandeep K. Srivastava, Shantu G. Amin, Subash C. Jonnalagadda, Tulin Budak-Alpdogan, Manoj K. Pandey
Diterbitkan 2024-10-01
Artikel -
3
Mcl-1 Inhibition: Managing Malignancy in Multiple Myeloma oleh Omar S. Al-Odat, Omar S. Al-Odat, Max von Suskil, Max von Suskil, Robert J. Chitren, Robert J. Chitren, Weam O. Elbezanti, Weam O. Elbezanti, Sandeep K. Srivastava, Tulin Budak-Alpddogan, Subash C. Jonnalagadda, Bharat B. Aggarwal, Manoj Pandey
Diterbitkan 2021-07-01
Artikel -
4
Comparative engraftment and clonality of macaque HSPCs expanded on human umbilical vein endothelial cells versus non-expanded cells oleh Sandeep K. Srivastava, Lauren L. Truitt, Chuanfeng Wu, Adam Glaser, Daniel J. Nolan, Michael Ginsberg, Diego A. Espinoza, Samson Koelle, Idalia M. Yabe, Kyung-Rok Yu, Sogun Hong, Stephanie Sellers, Allen Krouse, Aylin Bonifacino, Mark Metzger, Pradeep K. Dagur, Robert E. Donahue, Cynthia E. Dunbar, Sandhya R. Panch
Diterbitkan 2021-03-01
Artikel